Objective: To discuss current and potential treatment options for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA). Data Sources: A MEDLINE search (1966-January 2007 ...
It is the most common lethal nosocomial, or hospital-acquired, infection. The term "pneumonia" describes a group of symptoms that may be caused by bacteria, viruses, parasites, or fungi.
Hospital-acquired pneumonia develops in hospital while being treated for another condition; people in intensive care on breathing machines are particularly at risk of this. Fungal pneumonia is ...
The American Thoracic Society has published practice guidelines for the management of both community-acquired and hospital-acquired pneumonia. These guidelines suggest evaluation, therapy ...
Infections requiring hospitalization were associated with increased risk for future incident heart failure, regardless of infection and HF subtype, according to new data published in the Journal ...
Nosocomial pneumonia (give with an aminoglycoside): 4.5g every 6hrs for 7–14 days (continue aminoglycoside for P. aeruginosa); renal impairment (CrCl 20–40mL/min): 3.375g every 6hrs ...